SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-17-040206
Filing Date
2017-02-13
Accepted
2017-02-13 14:56:03
Documents
2
Group Members
EDWIN M. KANIA, JR.FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLCFLAGSHIP VENTURES FUND IV, L.P.FLAGSHIP VENTURES GENERAL PARTNER LLCNOUBAR B. AFEYAN, PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d333757dsc13ga.htm SC 13G/A 101101
2 EX1 d333757dex991.htm EX-99.1 10114
  Complete submission text file 0001193125-17-040206.txt   112871
Mailing Address 55 CAMBRIDGE PARKWAY, 8TH FLOOR CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY, 8TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund 2004 L P (Filed by) CIK: 0001299790 (see all company filings)

IRS No.: 201399649
Type: SC 13G/A

Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Subject) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88541 | Film No.: 17598443
SIC: 3841 Surgical & Medical Instruments & Apparatus